Get started
Author

Hameed Adelabu

Observed names: Adelabu, Hameed, Hameed ADELABU, Hameed Adewale Adelabu
ORCID: 0000-0002-1834-6291
Observed ORCID: 0000-0002-1834-6291
OpenAlex ID: A5077325229
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study
2018 · Seth C Inzaule, Raph L Hamers, et al. · The Lancet HIV · 78
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial
2024 · Bosede B Afolabi, Ochuwa A Babah, et al. · The Lancet Global Health · 43
Development of antepartum risk prediction model for postpartum hemorrhage in Lagos, Nigeria: A prospective cohort study (Predict‐PPH study)
2024 · Kehinde S. Okunade, Aloy O. Ugwu, et al. · International Journal of Gynecology & Obstetrics · 12
PDF
Prenatal anaemia and risk of postpartum haemorrhage: a cohort analysis of data from the Predict-PPH study
2024 · Kehinde S. Okunade, Adebola A. Adejimi, et al. · BMC Public Health · 9
PDF
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9–14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial
2024 · Kehinde S. Okunade, Adebola A. Adejimi, et al. · BMC Cancer · 7
Prognostic Performance of Pretreatment Systemic Immune-Inflammation Index in Women with Epithelial Ovarian Cancer
2023 · Kehinde S Okunade, Sarah O John-Olabode, et al. · Future Science OA · 6
Hepatitis B and C Virus Co-Infection and Their Association With Liver Disease in Persons With HIV in Nigeria
2024 · Emuobor Odeghe, Ganiyat Oyeleke, et al. · Journal of the International Association of Providers of AIDS Care (JIAPAC) · 5
Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial
2026 · Bosede Bukola Afolabi, Ochuwa Adiketu Babah, et al. · The Lancet Global Health · 4
Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)–Study protocol
2023 · Kehinde S. Okunade, Kabir B. Badmos, et al. · PLoS ONE · 4
PDF
Randomized Controlled Trial of Impact of Mobile Health Technologies on Human Papillomavirus Vaccination Uptake in Mothers of Vaccine-Eligible Girls in Lagos, Nigeria (mHealth-HPVac)
2025 · Kehinde Sharafadeen Okunade, Ayomide I. Fayinto, et al. · JCO Global Oncology · 3
Prevalence and determinants of moderate-to-severe anaemia in the third trimester of pregnancy: a multicenter cross-sectional study in Lagos, Nigeria
2024 · Kehinde S. Okunade, Festus O. Olowoselu, et al. · Scientific Reports · 3
Adapting the 2022 WHO verbal autopsy tool for use in Lagos State, Nigeria: insights from the LVASA-SRS project
2025 · Adeyemi Okunowo, Uchenna Gwacham-Anisiobi, et al. · BMC Research Notes · 2
PDF
Incidence and Antepartum Risk Factors of Severe Postpartum Haemorrhage in Anaemic Pregnant Women in Lagos, Nigeria: A Secondary Cohort Analysis
2024 · Kehinde S Okunade, Olufemi A Oyedeji, et al. · Cureus · 2
PDF
Patients’ perceptions of care in a Type 1 hybrid effectiveness-implementation trial on intravenous iron for anaemia in pregnancy in Nigeria
2026 · Mobolanle Balogun, Opeyemi R. Akinajo, et al. · PLoS ONE · 1
PDF
Improving Malaria Case Management: A baseline and endline assessment of community pharmacists and medicine vendors in Nigeria
2026 · Awodele, Olufunsho, Ogbulafor, Nnenna, et al. · West African Journal of Pharmacy · 1
Effect of Socioeconomic Status on Cervical Cancer Screening Behaviour Among Mothers of Adolescent Girls in Lagos, Nigeria: A Secondary Analysis of the mHealth-HPVac Study
2026 · Kehinde S. OKUNADE, Adaiah SOIBI-HARRY, et al. · Research Square · 1
PDF
Arterolane and piperaquine Vs. artemether and lumefantrine in uncomplicated malaria: A randomized study in Nigeria
2025 · Olufunsho Awodele, Ibrahim Sebutu Bello, et al. · International Journal of Infectious Diseases · 1
PDF
Impact of obesity on survival outcomes of women with advanced epithelial ovarian cancer in Lagos, Nigeria: a retrospective cohort study
2024 · Kehinde S Okunade, Olukayode O Akinmola, et al. · ecancermedicalscience · 1
Prevalence and Associated Factors of High-Risk Human Papillomavirus Infections among Human Immunodeficiency Virus-Infected Women in Lagos, Nigeria
2024 · Kehinde S. OKUNADE, Kabir B. BADMOS, et al. · Research Square · 1
PDF
Supplementary dataset for Outdoor Health IEC Visibility, Design, and Digital Readiness Audit in Lagos
2026 · Balogun, Noimot Abisola, Adelabu, Hameed, et al. · Figshare
Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trial
2026 · Bosede B Afolabi, Victoria O Adaramoye, et al. · The Lancet Global Health
Health-Related Quality of Life Among Individuals with HBV Mono-Infection and HIV/HBV Co-Infection in Sub-Saharan Africa
2026 · Edith Okeke, Joan Rugemalila, et al. · SSRN Electronic Journal
Abstract 21: Awareness and Acceptance of Human Papillomavirus Vaccination and Associated Factors Among HIV- Infected Mothers of Girls Aged 9 to 14 Years in Lagos, Nigeria (Aware-HPVac Study)
2025 · Kehinde S. Okunade, Ayokunle M. Olumodeji, et al. · Cancer Epidemiology Biomarkers & Prevention
Adapting the 2022 WHO Verbal Autopsy Tool for Use in Lagos State, Nigeria: Insights from the LVASA-SRS Project
2025 · Adeyemi Okunowo, Uchenna Gwacham-Anisiobi, et al.
Topical 5-Fluorouracil and Imiquimod for the Treatment of High-Grade Cervical Intraepithelial Neoplasia: Protocol for a Randomised Open-Label Controlled Trial (TOPFIT-CIN Study)
2025 · KEHINDE SHARAFADEEN OKUNADE, Ayomide I. FAYINTO, et al. · Research Square
PDF
Works count: 32
Citation count: 184
H-index: 6
I10-index: 3
Year
Topic
Type